Recombinant multi-species SOCS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SOCS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by a subset of cytokines, including IL2, IL3 erythropoietin (EPO), CSF2/GM-CSF, and interferon (IFN)-gamma. The protein encoded by this gene functions downstream of cytokine receptors, and takes part in a negative feedback loop to attenuate cytokine signaling. Knockout studies in mice suggested the role of this gene as a modulator of IFN-gamma action, which is required for normal postnatal growth and survival. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AISIMD,CIS1,CISH1,Cish1,Cish7,JAB,JAK-binding protein (JAB),SOCS-1,SOCS1,SSI-1,SSI1,STAT-induced STAT inhibitor 1 (SSI-1),Socs-1,Socs1,Suppressor of cytokine signaling 1,TIP-3,TIP3,Tec-interacting protein 3 (TIP-3)

Target products collectionGo to SOCS1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T06800-Ag-1/ GM-Tg-hg-T06800-Ag-2 Human SOCS1 protein Human
GM-Tg-rg-T06800-Ag-1/ GM-Tg-rg-T06800-Ag-2 Rat SOCS1 protein Rat
GM-Tg-mg-T06800-Ag-1/ GM-Tg-mg-T06800-Ag-2 Mouse SOCS1 protein Mouse
GM-Tg-cynog-T06800-Ag-1/ GM-Tg-cynog-T06800-Ag-2 Cynomolgus/Rhesus macaque SOCS1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T06800-Ag-1/ GM-Tg-felg-T06800-Ag-2 Feline SOCS1 protein Feline
GM-Tg-cang-T06800-Ag-1/ GM-Tg-cang-T06800-Ag-2 Canine SOCS1 protein Canine
GM-Tg-bovg-T06800-Ag-1/ GM-Tg-bovg-T06800-Ag-2 Bovine SOCS1 protein Bovine
GM-Tg-equg-T06800-Ag-1/ GM-Tg-equg-T06800-Ag-2 Equine SOCS1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T06800-Ag-1/ GM-Tg-hg-T06800-Ag-2; GM-Tg-rg-T06800-Ag-1/ GM-Tg-rg-T06800-Ag-2;
GM-Tg-mg-T06800-Ag-1/ GM-Tg-mg-T06800-Ag-2; GM-Tg-cynog-T06800-Ag-1/ GM-Tg-cynog-T06800-Ag-2;
GM-Tg-felg-T06800-Ag-1/ GM-Tg-felg-T06800-Ag-2; GM-Tg-cang-T06800-Ag-1/ GM-Tg-cang-T06800-Ag-2;
GM-Tg-bovg-T06800-Ag-1/ GM-Tg-bovg-T06800-Ag-2; GM-Tg-equg-T06800-Ag-1/ GM-Tg-equg-T06800-Ag-2
Products Name SOCS1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SOCS1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SOCS1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.